Document Detail


Immunomodulation for type 1 diabetes mellitus.
MedLine Citation:
PMID:  20377666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Type 1 diabetes (T1D) is characterised by immune-mediated pancreatic islet beta-cell destruction. The initial immune response engenders secondary and tertiary responses which collectively result in impairment of beta-cell function, progressive destruction of beta-cells and consequent development of T1D. The process is insidious and may evolve over many years, with the overt expression of clinical symptoms becoming apparent only when most beta-cells have been destroyed. Over the last quarter century much investigation has been directed at interdicting the T1D disease process, both during the stage of evolution of the disease and at the time of disease onset. This chapter of the Yearbook of Advanced Technology and Treatments in Diabetes reviews the key articles that have appeared in this field between January 2008 and June 2009.
Authors:
J S Skyler
Related Documents :
15489006 - Circadian regulation of islet genes involved in insulin production and secretion.
11574396 - Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must th...
15889096 - Expanded t cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an i...
14693706 - Inhibition of lipase activity and lipolysis in rat islets reduces insulin secretion.
16731996 - Prediction of diabetic foot ulcer occurrence using commonly available clinical informat...
19388966 - The prevalence of type 2 diabetes and its associated health problems in a community-dwe...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of clinical practice. Supplement     Volume:  -     ISSN:  1368-504X     ISO Abbreviation:  Int J Clin Pract Suppl     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-04-09     Completed Date:  2010-10-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9712380     Medline TA:  Int J Clin Pract Suppl     Country:  England    
Other Details:
Languages:  eng     Pagination:  59-63     Citation Subset:  IM    
Affiliation:
Division of Endocrinology, Diabetes, and Metabolism, and Diabetes Research Institute, University of Miami, Miller School of Medicine, Miami, FL 33101-6960, USA. skyler@miami.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Diabetes Mellitus, Type 1 / immunology,  therapy*
Humans
Immunomodulation*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
Next Document:  Exercise equipment and diabetes.